| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |